ArticleJournal of pharmaceutical policy and practice2024

Australian access to FDA-approved breakthrough therapy designation medicines: a 10-year review.

Senthil Lingaratnam et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.